CompletedNCT02302274
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Studying Brugada syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Steven Fowler, MDNYU School of Medicine
- Intervention
- flecainide iv(drug)
- Enrollment
- 209 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2010 – 2017
Study locations (1)
- New york University, School of Medicine, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02302274 on ClinicalTrials.govOther trials for Brugada syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06647927GenLab: Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise DiagnosisIRCCS Policlinico S. Donato
- RECRUITINGNCT06988189Unmasking Concealed Arrhythmia SyndromesImperial College London
- RECRUITINGNANCT05643209Brugada Syndrome Substrate Characterization and AblationMaria Cecilia Hospital
- RECRUITINGNCT05521451Clinical Cohort Study - TRUSTUniversitätsklinikum Hamburg-Eppendorf
- ACTIVE NOT RECRUITINGNANCT05685134Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome: a Randomized, Sham-controlled, Masked Clinical TrialUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGNCT04257994Distribution of Cell-cell Junction Proteins in Arrhythmic DisordersSt. George's Hospital, London
- ENROLLING BY INVITATIONNCT02413450Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac ArrhythmiasJohns Hopkins University
- RECRUITINGNCT05283759UZ Brussel HRMC Registry of Brugada SyndromeUniversitair Ziekenhuis Brussel